Sanofi to Cut 466 Jobs as Part of R&D Reorganization

| By | Sanofi
0
103

Sanofi said a reorganization of its research and development operation in Germany and France would result in 466 job cuts in the two countries.

In an emailed statement, a spokesman with the French drugmaker said the reshuffle aimed at enabling Sanofi to concentrate its research efforts in cancer, immunology, rare diseases and vaccines.

The company would end new research efforts in cardiology, the spokesman added, solely keeping existing research programs.

The 466 job cuts are to be implemented on a voluntary basis, Sanofi said. The company currently employs 15,000 in R&D worldwide out of a total staffing of more than 100,000.

SOURCE: reuters.com
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.